Full video transcriptClick to expand
Auto-generated transcript of @andresthedietitian's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00NAD+, pills or should you be doing injections?
- 0:03Here's what most people get wrong.
- 0:06Now, pills like these, which usually are NMN or NR,
- 0:11are just precursors, which means your body still needs
- 0:14to convert them to NAD+, in the system.
- 0:17And actually, you only absorb about 20 to 30%.
- 0:20Now, injections, on the other hand,
- 0:22they are direct NAD+, deliver into your system.
- 0:26There's no conversion needed.
- 0:28You get up to 90% plus absorption
- 0:31and the effects kick down way faster.
- 0:34Now, I'm personally testing this out
- 0:36and I've been doing these injections
- 0:37for about a month and a half.
- 0:38And I can tell you, I can tell the difference
- 0:41because I've also taken the pills before.
- 0:43I have totally noticed that shift in energy, my focus,
- 0:46honestly, within the first few days
- 0:48and even my wife tells me,
- 0:50it seems like you have more energy in general.
- 0:52And honestly, pills can work too.
- 0:54But if you're like me, you're over 35,
- 0:57juggling kits and a bunch of stuff,
- 0:59and you're really trying to optimize your recovery,
- 1:02I think injections are the way to go.
- 1:04I personally get mine from IVRX,
- 1:06which is a company that they provide
- 1:08these here in the United States
- 1:09and also Dr. Prescribe,
- 1:11which actually have my own prescription for it in here.
- 1:14I'm gonna continue to document my experience with this
- 1:17for three months.
- 1:18So if you're curious whether this stuff works or not,
- 1:20make sure you follow along.
- 1:22And if you wanna get it from a reputable source,
- 1:24check out IVRX, there's a link in my bio to get it.
NAD+ injections vs. supplements: what the evidence actually shows
Quick answer
The video promotes subcutaneous NAD+ injections over oral NMN/NR precursors, citing superior absorption and faster subjective effects observed over roughly six weeks of personal use. While injection-based delivery does bypass gut-mediated conversion steps, the specific bioavailability figures cited (20-30% oral, 90%+ injectable) are not established in peer-reviewed clinical trials and appear to derive from product marketing. The creator holds an affiliate relationship with the supplier, which is a material conflict of interest that viewers should weigh when evaluating the recommendation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For NAD+ injections vs. supplements: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "NAD+ injections vs. supplements: what the evidence actually shows" from Andres | Fat Loss Dietitian. We read the clip as a Peptide social video fact-checks claim about NAD+ Peptide Complex, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video promotes subcutaneous NAD+ injections over oral NMN/NR precursors, citing superior absorption and faster subjective effects observed over roughly six weeks of personal use.
The reason this review is not generic is the source wording and the canonical claim label "peptides should you get nad injections or stick with the supplement f." In this clip, the useful excerpt is: "NAD+, pills or should you be doing injections?" That wording changes the review because it points to NAD+ Peptide Complex safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. NAD+ Peptide Complex still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video promotes subcutaneous NAD+ injections over oral NMN/NR precursors, citing superior absorption and faster subjective effects observed over roughly six weeks of personal use.
FormBlends verdict
NAD+ Peptide Complex safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video promotes subcutaneous NAD+ injections over oral NMN/NR precursors, citing superior absorption and faster subjective effects observed over roughly six weeks of personal use. While injection-based delivery does bypass gut-mediated conversion steps, the specific bioavailability figures cited (20-30% oral, 90%+ injectable) are not established in peer-reviewed clinical trials and appear to derive from product marketing. The creator holds an affiliate relationship with the supplier, which is a material conflict of interest that viewers should weigh when evaluating the recommendation.
- Oral NMN and NR are precursors that require enzymatic conversion to NAD+, a fact supported by Yoshino et al. (2021, Science), though individual conversion efficiency varies widely and is not reliably captured by any single percentage.
- The '90% plus absorption' figure for subcutaneous NAD+ injections does not appear in peer-reviewed pharmacokinetic literature and should be treated as an unverified marketing claim until a published clinical trial establishes it.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- Oral NMN and NR are precursors that require enzymatic conversion to NAD+, a fact supported by Yoshino et al. (2021, Science), though individual conversion efficiency varies widely and is not reliably captured by any single percentage.
- The '90% plus absorption' figure for subcutaneous NAD+ injections does not appear in peer-reviewed pharmacokinetic literature and should be treated as an unverified marketing claim until a published clinical trial establishes it.
- No large-scale randomized controlled trial has demonstrated that NAD+ injections produce measurable longevity or recovery outcomes in healthy humans. Most human data remains limited to blood NAD+ metabolite levels, not hard clinical endpoints.
- Subcutaneous NAD+ products are compounded, not FDA-approved drugs. Quality and sterility depend on the individual compounding pharmacy, a material risk factor the video does not address.
- The creator holds an affiliate relationship with IVRX (disclosed via #ivypartner and #ivyaffiliate hashtags), which is a direct financial conflict of interest that viewers should factor into how they weigh his recommendation.
- Subjective energy improvements reported over six weeks by someone with an affiliate stake in the product, and corroborated only by a spouse, provide no reliable evidence of efficacy beyond placebo response.
- If you are interested in NAD+ supplementation in any form, a prescribing clinician with no financial relationship to a supplier is the appropriate starting point for evaluating risk, cost, and whether the evidence justifies the intervention for your specific situation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @andresthedietitian actually say?
The creator, a registered dietitian, argues that NMN and NR supplements are merely precursors requiring conversion inside the body, with only "20 to 30%" absorption. Injections, he claims, deliver NAD+ directly with "up to 90% plus absorption" and faster onset. He personally uses IVRX, says he has a prescription, and reports noticeably better energy and focus within "the first few days." His wife has also supposedly noticed the difference. He recommends injections specifically for people over 35 who are trying to optimize recovery, and links to the supplier in his bio. The hashtags #ivypartner and #ivyaffiliate signal a paid or affiliate relationship, which is worth keeping in mind when evaluating the enthusiasm here.
Does the science back this up?
Partially, but the specific absorption numbers he cites are not well-supported in peer-reviewed literature, and some of the framing oversimplifies a genuinely complicated area of research.
On the precursor point, he is broadly correct. NMN and NR are not NAD+ themselves. They enter cells through distinct transporters and get converted via enzymatic pathways. Yoshino et al. (2021, Science) confirmed that orally administered NMN raises blood NAD+ metabolite levels in humans, but the degree of conversion varies considerably between individuals and tissues. The "20 to 30%" bioavailability figure he quotes for oral NMN or NR is not sourced to any specific study in the video, and published estimates range more widely than that range suggests.
On the injection side, intravenous NAD+ does bypass gut absorption entirely, so the pharmacokinetic logic is sound in principle. But "90% plus absorption" for subcutaneous NAD+ injections, which is what IVRX appears to sell, is a marketing-adjacent claim. There is no robust clinical trial in a peer-reviewed journal establishing that specific figure for subcutaneous delivery. Clement et al. (2019, npj Aging) examined NAD+ metabolism but did not establish subcutaneous bioavailability benchmarks.
What did they get wrong (or right)?
He got the basic biochemistry directionally right. Oral precursors do require conversion, and injection-based delivery does sidestep gut absorption. Those are fair points. Where he went wrong is in presenting exact, confident percentages, "20 to 30%" and "90% plus," without citing any source. Those numbers appear to come from brand marketing rather than clinical data.
His personal anecdote, better energy within "the first few days" and his wife noticing a change, is not evidence of anything beyond placebo response or natural variation. Subjective energy improvements over six weeks, while on an affiliate-sponsored product, tell us almost nothing scientifically. To his credit, he does not claim NAD+ injections treat any specific disease, and he acknowledges that pills "can work too." He also discloses the prescription and the affiliate relationship via hashtags, even if that disclosure is buried.
What is missing entirely: any discussion of cost, the absence of long-term safety data for repeated NAD+ injections, or the fact that NAD+ given intravenously degrades rapidly in blood and its downstream effects at the cellular level are still being studied.
What should you actually know?
NAD+ research is legitimately interesting, but it is still early. The strongest human data exists for oral NR and NMN raising NAD+ levels in blood, not for hard clinical outcomes like disease reversal or measurable longevity extension in humans. Rajman et al. (2018, Cell Metabolism) reviewed the preclinical and early human evidence and described the field as promising but pre-conclusive.
Subcutaneous NAD+ injections are not FDA-approved as a drug for any indication. They are compounded products, meaning quality, sterility, and dosing consistency depend entirely on the compounding pharmacy. That does not make them automatically unsafe, but it is a meaningful caveat that a dietitian with an affiliate link has a financial reason not to mention.
If you are considering any injectable NAD+ product, the conversation belongs with a licensed prescribing clinician who has no financial stake in the outcome, not primarily with a TikTok review. The prescription he mentions is a reasonable starting point, but it should be paired with an honest risk-benefit discussion, not a link in a bio.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Andres | Fat Loss Dietitian · TikTok creator
7.3K views on this video
Should you get NAD+ Injections or stick with the supplement form? #menshealth #cellularhealth #longevity #ivypartner #ivyaffiliate #dietitian #biohacking
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about oral nmn?
Oral NMN and NR are precursors that require enzymatic conversion to NAD+, a fact supported by Yoshino et al. (2021, Science), though individual conversion efficiency varies widely and is not reliably captured by any single percentage.
What does the video say about the '90% plus absorption' figure for subcutaneous nad+ injections does?
The '90% plus absorption' figure for subcutaneous NAD+ injections does not appear in peer-reviewed pharmacokinetic literature and should be treated as an unverified marketing claim until a published clinical trial establishes it.
What does the video say about no large-scale randomized controlled trial has demonstrated?
No large-scale randomized controlled trial has demonstrated that NAD+ injections produce measurable longevity or recovery outcomes in healthy humans. Most human data remains limited to blood NAD+ metabolite levels, not hard clinical endpoints.
What does the video say about subcutaneous nad+ products?
Subcutaneous NAD+ products are compounded, not FDA-approved drugs. Quality and sterility depend on the individual compounding pharmacy, a material risk factor the video does not address.
What does the video say about the creator holds an affiliate relationship with ivrx (disclosed via?
The creator holds an affiliate relationship with IVRX (disclosed via #ivypartner and #ivyaffiliate hashtags), which is a direct financial conflict of interest that viewers should factor into how they weigh his recommendation.
What does the video say about subjective energy improvements reported over six weeks by someone with?
Subjective energy improvements reported over six weeks by someone with an affiliate stake in the product, and corroborated only by a spouse, provide no reliable evidence of efficacy beyond placebo response.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Andres | Fat Loss Dietitian, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.